Company intelligence / Profile preview
Melior Pharmaceuticals
Exton, Pennsylvania, United Statesmeliorpharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Melior Pharmaceuticals is a mid-stage biopharmaceutical company leveraging proprietary drug-repositioning technology to develop de-risked small molecule therapies. Its lead candidate, tolimidone, has completed Phase 2a and recently finished enrollment in a Phase 2b trial for type 2 diabetes with positive safety and efficacy data. Tolimidone is also being developed for NASH based on promising preclinical results. Mesocarb is in development for Parkinson’s disease dyskinesia and sleep disorders, supported by extensive prior human exposure outside the US[1][3][10].
- Therapeutic areas
- GastroenterologyEndocrinologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
No major pharma partnerships directly listed under Melior Pharmaceuticals itself as of current data. However, its affiliate Melior Discovery has partnered with Pfizer, Merck & Co., Johnson & Johnson, AstraZeneca regarding drug repositioning technology[5].
Beyond the preview
Go deeper on Melior Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Melior Pharmaceuticals.